benzonidazole has been researched along with Cirrhosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arana-Argaez, VE; Bottazzi, ME; Cruz-Chan, JV; Dumonteil, E; Dzul-Huchim, VM; Gusovsky, F; Hotez, P; Martinez-Vega, PP; Ortega-Lopez, J; Ramirez-Sierra, MJ; Rosado-Vallado, ME; Villanueva-Lizama, LE | 1 |
| Almeida, IC; Begum, K; Cardenas-Ovando, RA; Fernández-Figueroa, EA; Iandra da Silva Ferreira, B; Lannes-Vieira, J; Moreira, OC; Pereira, IR; Roy, S; Silva Grijó Farani, P; Vilar-Pereira, G | 1 |
| Cevey, ÁC; Donato, M; Gelpi, RJ; Goren, NB; Mirkin, GA; Penas, FN; Rada, MJ | 1 |
| Bahia, MT; Caldas, IS; Caldas, S; Diniz, LF; Menezes, APJ; Nascimento, ÁFDSD; Novaes, RD | 1 |
| Araújo, MS; Carneiro, CM; Lana, Md; Machado-de-Assis, GF; Martins, HR; Martins-Filho, OA; Oliveira, MT; Oliveira-Silva, JC; Paiva, NC | 1 |
| Azevedo, MA; Bahia, MT; Caldas, IS; da Matta Guedes, PM; da Silva do Nascimento, AF; de Figueiredo Diniz, L; de Lima, WG; dos Santos, FM; Martins, TA; Neto, RM; Talvani, A; Torres, RM | 1 |
6 other study(ies) available for benzonidazole and Cirrhosis
| Article | Year |
|---|---|
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
Topics: Adjuvants, Immunologic; Animals; Chagas Disease; Dogs; Fibrosis; Humans; Inflammation; Mice; Mice, Inbred BALB C; Nitroimidazoles; Perforin; Protozoan Vaccines; Recombinant Proteins; Toll-Like Receptor 4; Trypanosoma cruzi; Vaccines, Combined; Vaccines, DNA | 2022 |
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Mice; MicroRNAs; Nitroimidazoles; Pentoxifylline; Transcriptome; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.
Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Diastole; Fenofibrate; Fibrosis; Humans; Inflammation; Interleukin-6; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Nitroimidazoles; PPAR alpha; Stroke Volume; Trypanocidal Agents; Trypanosoma cruzi; Tumor Necrosis Factor-alpha; Ventricular Dysfunction; Ventricular Function | 2017 |
Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chronic Disease; Collagen Type III; Disease Models, Animal; Disease Progression; DNA, Protozoan; Dogs; Drug Resistance; Fibrosis; Heart; Myocardium; Nitroimidazoles; Parasite Load; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
Topics: Animals; Antibodies, Protozoan; Area Under Curve; Brazil; Chagas Disease; Child; Disease Models, Animal; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Flow Cytometry; Humans; Inflammation; Mice; Myocardium; Nitroimidazoles; Parasitemia; Polymerase Chain Reaction; Primary Cell Culture; Remission Induction; Statistics, Nonparametric; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.
Topics: Animals; Atrioventricular Block; Chagas Disease; Chronic Disease; Cicatrix; Collagen; Dogs; Drug Resistance; Electrocardiography; Fibrosis; Heart Atria; Myocardium; Nitroimidazoles; Prospective Studies; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2013 |